FEATURE: From Theory To Precision: Wales’ Life Science Ecosystem Homes In On Targets
This article was originally published in Clinica
The life sciences ecosystem in Wales is creating a bit of a buzz, and speakers at the recent BioWales annual event were able to point to the new funding opportunities and networking support that are helping to translate good ideas into market realities. We report the key BioWales 2016 takeaways here, and feature the views of Life Sciences Hub Wales COO Ian Barwick on how nascent medtech ventures are using the local infrastructure to good advantage
You may also be interested in...
As the UK enters the final week of its 47-year membership of the EU, UK medtech industry and commentators look ahead to the routes beyond Brexit for the UK, and a likely intense and often rocky 11 months of trade deal negotiations with EU and global partners. This article is part one of two.
Discussions on the shape of health care have moved from “reimagining” to the next stage: building and executing on the vision. That is the thrust of EY’s NextWave Report: New Horizons 2019. Additionally, for medtechs seeking business continuum, “duality” is now a preoccupying thought.
Point-of-care/near-patient testing has been “two years away from major breakthrough” for at least two decades, but fast access to data via automation and IT means that progress might change at last. How the tests are paid for remains an issue. The future of POC was the theme of an investor discussion at the first DxPx conference, held during the Medica 2019 event in Germany.